T2Resistance
Device
T2 Biosystems, Inc.
Total Payments
$1.6M
Transactions
7
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $814,115 | 5 | 0 |
| 2022 | $829,491 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.6M | 7 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 510(k) Study for T2Resistance | T2 Biosystems, Inc. | $829,491 | 0 |
| T2Resistance Clinical Trial Study | T2 Biosystems, Inc. | $764,115 | 0 |
| Effect of direct-from-blood bacterial testing on antibiotic administration and clinical outcomes | T2 Biosystems, Inc. | $50,000 | 0 |
Top Doctors Receiving Payments for T2Resistance
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Providence, RI | $1.6M | 7 |
Ad
Manufacturing Companies
- T2 Biosystems, Inc. $1.6M
Product Information
- Type Device
- Total Payments $1.6M
- Total Doctors 0
- Transactions 7
About T2Resistance
T2Resistance is a device associated with $1.6M in payments to 0 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is T2 Biosystems, Inc..
Payment data is available from 2022 to 2023. In 2023, $814,115 was paid across 5 transactions to 0 doctors.
The most common payment nature for T2Resistance is "Unspecified" ($1.6M, 100.0% of total).
T2Resistance is associated with 3 research studies, including "510(k) Study for T2Resistance" ($829,491).